Mounting Pressure on Palantir's UK Public Contracts and NHS Deal
Data analytics giant Palantir's public contracts in the UK, particularly the £330 million National Health Service (NHS) agreement, face intense parliamentary and public scrutiny. Concerns over the company's data access and compatibility with British values are causing fluctuations in Palantir's stock performance.
Palantir Technologies (PLTR), the U.S.-based data analytics firm, is facing increasing political and public pressure over its public sector contracts with the UK government, which collectively exceed £670 million. The most prominent of these agreements is the approximately £330 million data platform deal with the National Health Service (NHS). Both the British Parliament and civil society organizations are calling for a review of this agreement, citing concerns over the company's access to sensitive patient data, reliance on a foreign firm, and perceived incompatibility with British values.
Palantir's involvement with the NHS began with a symbolic £1 contract during the pandemic in 2020, evolving into a £330 million deal for the NHS Federated Data Platform by 2023. Additionally, in December 2025, the company secured a £240 million data analytics contract with the UK Ministry of Defence. While this expanding footprint signals significant growth in the public sector, it has also become a subject of intense debate.
The UK's Science, Innovation and Technology Committee has urged the government to terminate the NHS contract with Palantir and explore in-house or UK-based alternatives. The committee identified Palantir as the most concerning example of the public sector's growing reliance on a small number of major technology providers, including Microsoft and Amazon Web Services. This scrutiny contributed to a dip in Palantir's shares in June 2026, though the stock saw a rebound in March 2026 following news of a short-term trial contract with the UK's Financial Conduct Authority (FCA).
Palantir has demonstrated robust revenue growth in recent years. The company reported a 70% year-over-year revenue increase in the fourth quarter of 2025, with U.S. government revenue growing by 66% and U.S. commercial revenue by 137% annually. Its total revenue for 2025 reached $4.475 billion, surpassing expectations. The company continues its growth trajectory driven by accelerating demand for its Artificial Intelligence Platform (AIP) and expansion across both government and commercial customers.
These developments are set against a broader economic and political backdrop where AI and data analytics platforms are becoming critical for national security and public services. Governments require the advanced capabilities offered by companies like Palantir but are simultaneously grappling with issues of data sovereignty, privacy concerns, and the imperative to develop domestic technological capabilities. Switzerland's conclusion that Palantir's architecture cannot prevent U.S. government access to sovereign data highlights the international dimension of these concerns.
Analysts and market observers note that decisions regarding Palantir's UK contracts will significantly impact the company's future revenue streams and its standing in the European market. While its partnerships with the U.S. government and leadership in AI present strong growth potential, political and ethical debates in key markets like the UK pose risks to its near-term growth trajectory. Palantir's strong cash generation and profit margins provide it with the financial resilience to navigate such challenges.
Related Symbols
💸 Ready to act on this news?
You need a brokerage account to invest. Compare 30+ trusted brokers in seconds — zero commission options available.
Comments (0)
No comments yet. Be the first to comment!

